PANCPanacos Pharmaceuticals Inc.

$0.00
$0.00
(0.00%)
Today
Updated: 10:31 AM EST
Mkt Cap$54.00
Vol120.00
50

Neutral Sentiment

How do you feel about PANC?

About

Panacos Pharmaceuticals, Inc. engages in the discovery and development of small-molecule oral drug which is designed to treat human immunodeficiency virus and other major human viral diseases. Its product candidate, bevirimat, which works by a novel mechanism of action called maturation inhibition. The company was founded by Graham Allaway in December 1992 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Panacos Pharmaceuticals, Inc.?

Latest PANC News

View
Top Discussions

Advertisement|Remove ads.